Breaking News, Promotions & Moves

Hummingbird Bioscience Appoints New CMO and COO

Names Kon Yew Kwek, BM BCh, DPhil, and Lisa Ooi, PhD, as Chief Medical Officer and Chief Operating Officer, respectively.

Author Image

By: Charlie Sternberg

Associate Editor

Hummingbird Bioscience, a precision biotherapeutics company, has appointed Kon Yew Kwek, BM BCh, DPhil, and Lisa Ooi, PhD, as Chief Medical Officer and Chief Operating Officer, respectively. Dr. Kon Yew Kwek, Chief Medical Officer Kwek is promoted to Chief Medical Officer, from Senior Vice President of Clinical Development. He joined the company in 2022 and brings two decades of experience from Akeso Biopharma, Eli Lilly and IQVIA and clinical practice. He will lead the company’s clinica...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters